ArticleProceedings of the National Academy of Sciences of the United States of America2020

Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients.

Chengliang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.